Eikon Therapeutics Closes $148 Million Series A Financing To Develop High-Throughput, Super-Resolution Microscopy For Drug Discovery
Amount Raised
$148 Million
Round Type
Series A
MillbraeBiotechnologyHealth CareTherapeuticsDescription
Eikon Therapeutics, Inc., a pioneer in live-cell super-resolution microscopy and engineering for drug discovery, today announced that it has closed a $148 million Series A financing led by The Column Group with participation from Foresite Capital, Innovation Endeavors and Lux Capital. The company also announced the appointment of Roger M. Perlmutter, MD, PhD, as its new Chief Executive Officer.
Quick answer
Eikon Therapeutics raised $148 Million in a Series A round, dated May 5, 2021. Eikon Therapeutics is based in Millbrae, California, United States.
- How much did Eikon Therapeutics raise?
- Eikon Therapeutics raised $148 Million in a Series A round on May 5, 2021.
- What does Eikon Therapeutics do?
- Eikon Therapeutics is advancing breakthrough therapies through the purposeful integration of science and engineering.
- Where is Eikon Therapeutics based and how big is it?
- Eikon Therapeutics is based in Millbrae, California, United States. Fundz records about 390 employees.
- Who are the decision-makers at Eikon Therapeutics?
- Fundz holds 1 contact at Eikon Therapeutics, including the Executive Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Eikon Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- OncoNano Medicine raised $50M (Series B) on June 17, 2021.
- Korsana Biosciences raised $18M on June 17, 2021.
- Camp4 Therapeutics Corp raised $45M (Funding Round) on June 15, 2021.
- BriaCell Therapeutics Corp. raised $27M on June 15, 2021.
- Synthekine raised $108M (Series B) on June 10, 2021.
- Dermavant raised $200M (Funding Round) on June 7, 2021.
Who to call at Eikon Therapeutics, and when
A new round usually means Eikon Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Eikon Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Eikon Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Eikon Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Eikon Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansEikon Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.